Frontlight ResearchEarly access
Metastatic breast cancer trials in Norway
1 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleDESTINY Breast Respond HER2-(Ultra)Low Europe
- Where
- Bodø, Drammen, Kristiansand, Skien, Tromsø
- Age
- 18 years and over
- People
- 2,295 worldwide
- Run by
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
See details and how to joinNCT05945732